Muscular dystrophy is caused by defects in certain genes, with type determined by the abnormal gene. In 1986, researchers discovered the gene that, when defective or flawed, causes Duchenne ...
While today the market is focused almost exclusively on gene therapy delivering partial ... 100% full-length human dystrophin for DMD and BMD. IPS HEART has also developed ISX-9-CPCs, a human ...
Topics include surface and interfacial properties of materials, surface characterization, protein adsorption, cell adhesion, foreign body response, immunomodulation, nanotechnology, gene delivery and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback